A diverse and experienced global network

Board of Directors

atbtherapeutics benefits from a strong and diverse Board of Directors with vast experience in company and product development within the fields of immunology and oncology

• Mark Throsby
  Chief Executive Officer
• Vincent Brichard
  EQT Venture partner
• Willem Broeckaert
  V-Bio director
• John de Koning
  EQT partner
• Pierre Detrixhe
  InvestSud
• Karin Nena Kleinhans
  MRLV executive director
• Bertrand Magy
  Chief Operating Officer